| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K20514654 |
| PharmacoGx | BRD-K20514654 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | C3orf20 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.0004 |
| mRNA | RASD1 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0004 |
| mRNA | MYT1 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0004 |
| mRNA | ATP2C2 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0004 |
| mRNA | UST | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0004 |
| mRNA | PLPPR3 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0004 |
| mRNA | DFFB | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0004 |
| mRNA | GOLGA8Q | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0005 |
| mRNA | NFAM1 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0005 |
| mRNA | KLF13 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0005 |
